Novotny William E, Fox Pam, Haislip Dynita
ECU Health Greenville North Carolina USA.
Clin Case Rep. 2024 Dec 12;12(12):e9602. doi: 10.1002/ccr3.9602. eCollection 2024 Dec.
Intranasal dexmedetomidine administration in clinically recommended doses has a small but important risk of causing catastrophic respiratory failure in the setting of preexisting severe respiratory workloads.
在临床推荐剂量下经鼻给予右美托咪定,在已有严重呼吸负荷的情况下,有导致灾难性呼吸衰竭的小但重要的风险。